Genetic factors in the pathogenesis of breast cancer: Their role and relative importance

Journal of Nutrition

Volumn 127, Issue 5 SUPPL., 1997, Pages

  Sellers, Thomas A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

breast cancer; genes; nutrition; review; risk factors

Indexed keywords

PROTEIN P53;

BREAST CANCER; CANCER RISK; CONFERENCE PAPER; ENVIRONMENTAL FACTOR; ESTROGEN METABOLISM; GENE MUTATION; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; PATHOGENESIS; PUBLIC HEALTH; RISK FACTOR;

EID: 33749122506     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/127.5.929s     Document Type: Conference Paper

References (34)

1. Andersen, T. I., Heimdal, K. R., Skrede, M., Tveit, K., Berg, K. & Børresen, A.-L. (1994) Oestrogen receptor (ESR) polymorphisms and breast cancer susceptibility. Hum. Genet. 94: 665-670.
2. Bernstein, L. (1993) Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15: 48-65.
3. Bradlow, H. L., Michnovicz, J. J., Telang, N., Osbome, M. P. & Goldin, B. R. (1992) Diet, oncogenes and tumor viruses as modulators of estrogen metabolism in vivo and in vitro. Cancer Detect. Prev. 16: S35-S41.
4. Chen, P.-L., Sellers,T. A., Rich, S. S., Potter, J. D. & Folsom A. R. (1994) Examination of the effect of non-genetic risk factors on the familial risk of breast cancer among relatives of postmenopausal breast cancer patients. Cancer Epidemiol. Biomarkers Prev. 3: 549-556.
5. Easton, D. F. (1994) Cancer risks in A-T heterozygotes. Int. J. Radiat. Biol. 66: S177-S182.
6. Evans, R. M. (1988) The steroid and thyroid hormone receptor superfamily. Science 240: 889-895.
7. Fitzgerald, M. G., MacDonald, D. J., Krainer, M., Hoover, I., O'Neil, E., Unsal, H., Silva-Arrieto, S., Finkelstein, D. M., Beer-Romero, P., Englert, C., Sgroi, D. C., Smith, B. L., Younger, J. W., Garber, J. E., Duda, R. B., Mayzel, K. A., Isselbacher, K. J., Friend, S. H. & Haber, D. A. (1996) Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N. Engl. J. Med. 334: 143-149.
8. Ford, D. & Easton, D. F. (1995) The genetics of breast and ovarian cancer. Br. J. Cancer 72: 805-812.
9. Ford, D., Easton, D. F., Bishop, D. T., Narod, S. A. & Goldgar, D. E. (1994) Risks of cancer in BRCA1 mutation carriers. Lancet 343: 692-695.
10. Ford, D., Easton, D. F. & Peto, J. (1995) Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am. J. Hum. Genet. 57: 1457-1462.
11. Gudmundsson, J., Johannesdottir, G., Bergthorsson, J. T., Arason, A., Ingvarsson, S., Egilsson, V. & Barkardottir, R. B. (1995) Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. Cancer Res. 55: 4830-4832.
12. Hall, J. M., Huey, B., Morrow, J., Newman, B., Lee, M., Jones, E., Carter, C., Buehring, G. C. & King, M.-C. (1990) Rare HRAS alleles and susceptibility to human breast cancer. Genomics 6: 188-191.
13. Henderson, B. E. & Bernstein, L. (1996) Endogenous and exogenous hormone factors. In: Diseases of the Breast (Harris, J. R., Lippman, M. E., Morrow, M. & Hellman, S., eds.), pp. 185-200. Lippincott-Raven Publishers, Philadelphia, PA.
14. Krontiris, T. G. (1990) Detection of cancer predisposition by hypervariable region analysis. Birth defects: original article series. J. Cell. Biochem. 26: 129-140.
15. Krontiris, T. G., Devlin, B., Karp, D. D., Robert, J. J. & Risch, N. (1993) An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N. Engl. J. Med. 329: 517-523.
16. Langsten, A. A., Malone, K. E., Thompson, J. D., Daling, J. R. & Ostrander E. A. (1996) BRCA1 mutations in a population-based sample of young women with breast cancer. N. Engl. J. Med. 334: 137-142.
17. Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Jr., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A. & Friend S. H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238.
18. Martucci, C. P. & Fishman, J. (1993) P450 enzymes of estrogen metabolism. Pharmacol. & Ther. 57: 237-257.
19. McKinnon, P. J. (1987) Ataxia-telangiectasia: an inherited disorder of ionizing-radiation sensitivity in man. Progress in the elucidation of the underlying biochemical defect. Hum. Genet. 75: 197-208.
20. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Shaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Morris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barrett, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A. & Skolnick, M. H. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71.
21. Narod, S., Ford, D., Devilee, P., Barkardottir, R. B., Eyfjord, J., Lenoir, G., Serova, O., Easton, D. & Goldgar D. (1995) Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium. Am. J. Hum. Genet. 57: 957-958.
22. National Cancer Institute SEER Program (1990) Cancer Statistics Review, 1973-1987. NIH Publication No. 90-2789. National Institute of Health, Bethesda, MD.
23. Osborne, M. P., Bradlow, H. L. Wong, G.Y.C. & Telang, N. T. (1993) Upregulation of estradiol C16α-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk. J. Natl. Cancer Instit. 85: 1917-1920.
24. Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D. & Part, F. F. (1995) Estrogen receptor gene analysis in estrogen receptor-positive and receptor-negative primary breast cancer. J. Natl. Cancer Instit. 87: 446-451.
25. Santibanez-Koref, M. F., Birch, J. M., Hartley, A. L., Jones, P. H., Craft, A. W., Eden, T., Crowther, D., Kelsey, A. M. & Harris, M. (1991) p53 gerrnline mutations in Li-Fraumeni syndrome. Lancet 338: 1490-1491.
26. Savitsky, K., Bar-Shira, A., Gilad, S., Rotman, G., Ziv, Y., Vanagaite, L., Tagle, D. A., Smith, S., Uziel, T., Sfez, S., Ashkenazi, M., Pecker, I., Frydman, M., Hamik, R., Patanjali, S. R., Simmons, A., Clines, G. A., Sartiel, A., Gatti, R. A., Chessa, L., Sanal, O., Lavin, M. F., Jaspers, N.G.J., Taylor, M. R., Artett, C. F., Miki, T., Weissman, S. M., Lovett, M., Cotlins, F. S. & Shiloh, Y. (1995) A single ataxia tetangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753.
27. Schneider, J., Huh, M. M., Bradlow, H. L. & Fishman, J. (1984) Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells. J. Biol. Chem. 259: 4840-4845.
28. Schneider, J., Kinne, D., Fracchia, A., Pierce, V., Anderson, K. E., Bradlow, H. L. & Fishman, J. (1982) Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc. Natl. Acad. Sci. U.S.A. 79: 3047-3051.
29. Sidransky, D., Tokino, T., Helzlsourer, K., Zehnbauer, B., Rausch, G., Shelton, B., Prestigiacomo, L., Vogelstein, B. & Davidson, N. (1992) Inherited p53 gene mutations in breast cancer. Cancer Res. 52: 2984-2985.
30. Telang, N. T., Osborne, M. P., Sweterlitsch, L. A., Narayanan, R. (1992) Neoplas- tic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul. 1: 863-872.
31. Wooster R., Ford D., Mangion J., Ponder B. A., Peto J., Easton D. F. & Stratton, M. R. (1993) Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum. Genet. 92: 91-94.
32. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B.A.J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S., Lenoir, G., Eglisson, V., Barkadottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A. & Stratton, M. R. (1995) Identification of the breast cancer susceptibility gene BRAC2. Nature (Lond.) 378: 789-792.
33. Yu, S. & Fishman, J. (1985) Interactions of histones with estrogens. Covalent adduct formation with 16α-hydroxyestrone. Biochemistry 29: 8017-8021.
34. Zuppan, P., Hall, J. M., Lee, M. K., Ponglikitmongkol, M. & King M.-C. (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset disease. Am. J. Hum. Genet. 48: 1065-1068.